Table 1. Baseline clinical characteristics of the study population.
| N = 34 | |
|---|---|
| Age, years | 64.8±13.1 |
| Male sex, n (%) | 23 (67.6) |
| BMI, kg/m2 | 22.9±3.5 |
| Hypertension, n (%) | 23 (67.6) |
| Dyslipidemia, n (%) | 14 (41.1) |
| DM, n (%) | 8 (23.5) |
| Current smoking, n (%) | 6 (17.6) |
| LVEF, % | 61.3±10.9 |
| sLR11, ng/ml | 11.2±4.6 |
| BNP, pg/ml | 373.6±827.6 |
| Creatinine, mg/dl | 1.22±1.59 |
| UA, mg/dl | 6.82±2.04 |
| RDW, % | 14.1±1.0 |
| HbA1C, % | 5.38±0.64 |
| mPA, mmHg | 20.7±7.7 |
| mPCWP, mmHg | 14.2±7.1 |
| CI, L/min/m2 | 2.52±0.44 |
| PVR, dyne/s/cm5 | 129.1±81.7 |
Data are presented as n (%) or mean ± standard deviation (SD).
BMI: Body mass index; BNP: Brain natriuretic peptide; CI: Cardiac index; DM: Diabetes mellitus; LVEF: Left ventricular ejection fraction; mPAP: Mean pulmonary artery pressure; PCWP: Pulmonary capillary wedge pressure; PVR: Pulmonary vascular resistance; RDW: RBC distribution width; UA: Uric acid.